Session Information
-
WCLC 2017
18th World Conference on Lung Cancer
Conference Program for the 18th World Conference on Lung Cancer in Yokohama, Japan
Download PDF of the Conference Program: Click Here.
Onsite Conference Program Addendum (17/10/2017): Click Here.
Download PDF of the Abstract Book: Click Here.
Financial Disclosure Summary (PDF): Click Here.Presentation Date(s):- Oct 15 - 18, 2017
- Total Presentations: 2295
October 14 Sat
Oct 14 Sunday
October 15 Sun
Oct 15 Monday
October 16 Mon
Oct 16 Tuesday
October 17 Tue
Oct 17 Wednesday
October 18 Wed
Oct 18
-
+
P1.03 - Chemotherapy/Targeted Therapy
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Chemotherapy/Targeted Therapy
-
+
P1.03-038 - A Phase I Trial of Afatinib and Bevacizumab in Untreated Patients with Advanced NSCLC Harboring EGFR-Mutations: OLCSG1404
09:30 - 09:30 | Presenter: Shoichi Kuyama | Author(s): Kenichiro Kudo, T. Tamura, T. Nishi, Daijiro Harada, A. Bessho, N. Fujimoto, D. Minami, K. Aoe, T. Ninomiya, K. Kiura
- Abstract
Loading...
-
+
OA 05 - Next Generation TKI
- 15:45 - 17:30
- 10/16/2017
- Location: Room 301 + 302
- Type: Oral
- Track: Advanced NSCLC
- Moderators:James Chih-Hsin Yang, Fiona Blackhall
-
+
OA 05.03 - Clinical Activity of ASP8273 in Asian Non-Small Cell Lung Cancer Patients with EGFR Activating and T790M Mutations
16:05 - 16:15 | Presenter: Keunchil Park | Author(s): K. Azuma, C. Tsai, Takashi Seto, H. Nokihara, James Chih-Hsin Yang, Sang-We Kim, H. Murakami, Makoto Nishio, K. Kiura, A. Inoue, K. Takeda, Jin-Hyoung Kang, Hidetoshi Hayashi, T. Nakagawa, Y. Kaneko, R. Akazawa, M. Shimazaki, S. Morita, M. Fukuoka, Kazuhiko Nakagawa
- Abstract
Loading... -
+
OA 05.08 - Final Result of Phase I/II Study (AF-001JP) of Alectinib, a Selective CNS-Active ALK Inhibitor, in ALK+ NSCLC Patients (Pts)
17:00 - 17:10 | Presenter: Makoto Nishio | Author(s): K. Kiura, Takashi Seto, Kazuhiko Nakagawa, M. Maemondo, A. Inoue, T. Hida, H. Yoshioka, M. Harada, Yuichiro Ohe, N. Nogami, H. Murakami, K. Takeuchi, S. Inamura, H. Kuriki, T. Shimada, T. Tamura
- Abstract
Loading...
-
+
P2.01 - Advanced NSCLC
- 09:00 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Advanced NSCLC
-
+
P2.01-034 - Phase I/II Trial of Weekly Nab-Paclitaxel as 2nd or 3rd Line Treatment in NSCLC Without Driver Mutations. (OLCSG1303)
09:00 - 09:00 | Presenter: Kenichiro Kudo | Author(s): Shoichi Kuyama, Daijiro Harada, T. Kozuki, A. Bessho, K. Hotta, H. Yoshioka, K. Gemba, N. Takigawa, I. Oze, K. Kiura
- Abstract
Loading...
-
+
MA 07 - ALK, ROS and HER2
- 15:45 - 17:30
- 10/17/2017
- Location: Room 316
- Type: Mini Oral
- Track: Advanced NSCLC
- Moderators:Robert C. Doebele, J.C. Ho
-
+
MA 07.11 - A Phase II Study of Trastuzumab Emtansine in HER2-positive Non-Small-Cell-Lung Cancer
16:55 - 17:00 | Presenter: Daijiro Harada | Author(s): T. Kozuki, N. Nogami, K. Hotta, K. Aoe, K. Ohashi, K. Ninomiya, T. Hirata, S. Hinotsu, Shinichi Toyooka, K. Kiura
- Abstract
Loading...
-
+
P3.01 - Advanced NSCLC
- 09:30 - 16:00
- 10/18/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Advanced NSCLC
-
+
P3.01-071 - Randomized Phase 1b/3 Study of Erlotinib + Ramucirumab in Untreated EGFR Mutation-Positive Stage IV NSCLC: Phase 1b Outcomes
09:30 - 09:30 | Presenter: Kazuhiko Nakagawa | Author(s): Edward Brian Garon, Luis Paz-Ares, S. Ponce, J. Corral Jaime, O. Juan Vidal, Ernest Nadal, K. Kiura, Keunchil Park, R.C. Widau, E. Alexandris, S. He, P. Lee, Martin Reck
- Abstract
Loading... -
+
P3.01-088k - Significance of Second Rebiopsy for Detecting T790M Mutation
09:30 - 09:30 | Presenter: Eiki Ichihara | Author(s): K. Hotta, T. Higashionna, T. Ninomiya, T. Kubo, K. Ohashi, M. Tabata, K. Kiura
- Abstract
Loading...
-
+
OA 12 - Emerging Genomic Targets
- 11:00 - 12:30
- 10/18/2017
- Location: F203 + F204 (Annex Hall)
- Type: Oral
- Track: Advanced NSCLC
- Moderators:H. Akita, Maurice Pérol
-
+
OA 12.03 - Clinical Features of Advanced Lung Cancer Harboring HER2 Aberrations: A Large Prospective Cohort Study (HER2-CS STUDY)
11:20 - 11:30 | Presenter: Shinobu Hosokawa | Author(s): A. Bessho, K. Ninomiya, T. Tanaka, N. Ishikawa, M. Yamasaki, T. Shibayama, K. Aoe, T. Kozuki, N. Fujimoto, K. Gemba, Y. Ueda, M. Inoue, T. Murakami, Shoichi Kuyama, H. Kawai, K. Fujitaka, K. Inoue, M. Takata, H. Yanai, K. Hotta, K. Kiura
- Abstract
Loading...
